微创机器人-B(02252)今日盘中股价大涨9.52%,引发市场广泛关注。
消息面上,微创机器人近期公布了最新业绩数据,该公司旗下腔镜、骨科、血管介入等核心产品的去年综合订单量已累计超过100台,表明公司产品获得了大量订单,业务增长良好。
具体来看,公司图迈腔镜手术机器人全球订单达39台、商业化订单突破30台;鸿鹄骨科手术机器人全球订单达25台,覆盖中国、美国、欧洲等多个市场;R-ONE血管介入机器人国内订单达8台。此外,公司的手术机器人产品已遍及全球近65个国家和地区,获得诸多认可,预计未来市场需求仍将保持强劲。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.